| abstract |
The present disclosure concerns compounds of Formula (I) n nor pharmaceutically acceptable salts thereof, wherein R 1 , R 2 and R 3 have any of the meanings defined hereinbefore in the description; processes for their preparation, pharmaceutical compositions containing them and their use in the treatment of cancer. |